Exelixis
EXEL
#1825
Rank
S$14.27 B
Marketcap
S$53.23
Share price
1.11%
Change (1 day)
8.30%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company